المؤلفون: N. Schönfeld, L. Barkane, I. Davoliene, M. Danilovits, S. Miliauskas, F. Ader, O.M. Kon, C. Lange, A. Duvignaud, M. Heiss-Neumann, N. Hittel, N. Lazarević, I. Knebel, A. Martin, B. Eschenbach, E. van Heumen, V. George

المصدر: IJTLD Open, Vol 1, Iss 6, Pp 274-278 (2024)

مصطلحات موضوعية: tuberculosis, multidrug-resistant tuberculosis, mdr-tb, pass, safety treatment outcomes, adverse events, european medicines agency, Diseases of the respiratory system, RC705-779

وصف الملف: electronic resource

Relation: https://www.ingentaconnect.com/contentone/iuatld/ijtldo/2024/00000001/00000006/art00006; https://doaj.org/toc/3005-7590

URL الوصول: https://doaj.org/article/012d585edc80495abb2f1cf7c1697488

المؤلفون: L Guglielmetti, Maia Kipiani, Petros Isaakidis, SK Brode, Jonathon R. Campbell, Parvaneh Baghaei, Payam Nahid, Rafael Laniado-Laborín, Lorenzo Guglielmetti, Zhiyi Lan, D Falzon, L Barkane, Vicky Chang, Dafne Paiva Rodrigues, D Menzies, R Singla, Denise Rodrigues, Z Lan, Noor Azlinda Ahmad, JR Campbell, R Laniado-Laborín, Jcm Brust, Nafees Ahmad, Christoph Lange, Andrea Benedetti, Dick Menzies, Zarir F Udwadia, P Nahid, Sarah K. Brode, A Benedetti, RR Kempker, P Baghaei, M Kipiani, Liga Kuksa, Rupak Singla, James C.M. Brust, Linda Barkane, Zarir F. Udwadia, Dennis Falzon, L Kuksa, P Isaakidis, Russell R. Kempker, Vwl Chang

المساهمون: Centre d'Immunologie et de Maladies Infectieuses (CIMI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS)

المصدر: Lancet Respir Med
The Lancet. Respiratory medicine, vol 8, iss 4
The Lancet Respiratory Medicine
The Lancet Respiratory Medicine, Elsevier, 2020, 8 (4), pp.383-394. ⟨10.1016/S2213-2600(20)30047-3⟩

مصطلحات موضوعية: Male, Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment 2017, Antitubercular Agents, Clofazimine, chemistry.chemical_compound, 0302 clinical medicine, Moxifloxacin, Levofloxacin, Tuberculosis, Multidrug-Resistant, 030212 general & internal medicine, Diarylquinolines, Lung, ComputingMilieux_MISCELLANEOUS, Incidence, Pulmonary, Multidrug-Resistant, Aminosalicylic Acid, 3. Good health, Infectious Diseases, 6.1 Pharmaceuticals, Meta-analysis, Public Health and Health Services, Female, Infection, Fluoroquinolones, medicine.drug, Adult, Pulmonary and Respiratory Medicine, Canada, medicine.medical_specialty, Tuberculosis, Drug-Related Side Effects and Adverse Reactions, Clinical Sciences, Article, 03 medical and health sciences, Rare Diseases, Internal medicine, medicine, Humans, Adverse effect, Tuberculosis, Pulmonary, Other Medical and Health Sciences, business.industry, Prevention, Linezolid, Evaluation of treatments and therapeutic interventions, Mycobacterium tuberculosis, medicine.disease, [SDV.MP.BAC]Life Sciences [q-bio]/Microbiology and Parasitology/Bacteriology, Discontinuation, Emerging Infectious Diseases, Orphan Drug, Good Health and Well Being, 030228 respiratory system, chemistry, Antimicrobial Resistance, Bedaquiline, business

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07461c3a4c3574948b0fd06e18795e8b
https://doi.org/10.1016/s2213-2600(20)30047-3